IL17A and type 1 diabetes mellitus: Despite this, several studies also point out that administration of GAD65 Alum intervention in stage 3 T1D patients contributes to the elevation of several inflammatory markers and cytokines, particularly IL-21 and IL-17, which play substantial roles in autoimmune assault of the β-cells, immune cell priming, and antigen secretion from B-cells.